2017
DOI: 10.4997/jrcpe.2017.302
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Melanoma: An Updated Sign Guideline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…Furthermore, we identified four more duplicates [ 15 , 16 , 17 , 18 ] and two records were excluded due to unclear methodological approaches [ 19 , 20 ]. One record did not present any recommendations [ 21 ], and two records provided a summary of existing guidelines [ 22 , 23 , 24 ]. Hence, six relevant guidelines published between 2017 and 2019 by consortia of Australia, France, Germany, Scotland, Spain and the United States of America were included in the appraisal ( Table 1 ) [ 25 , 26 , 27 , 28 , 29 , 30 ].…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, we identified four more duplicates [ 15 , 16 , 17 , 18 ] and two records were excluded due to unclear methodological approaches [ 19 , 20 ]. One record did not present any recommendations [ 21 ], and two records provided a summary of existing guidelines [ 22 , 23 , 24 ]. Hence, six relevant guidelines published between 2017 and 2019 by consortia of Australia, France, Germany, Scotland, Spain and the United States of America were included in the appraisal ( Table 1 ) [ 25 , 26 , 27 , 28 , 29 , 30 ].…”
Section: Resultsmentioning
confidence: 99%
“…Surgical excision and subsequent soft-tissue reconstruction for melanoma is preceded by a thorough process of initial diagnosis and staging. General practitioners are encouraged to refer all suspicious lesions in secondary or tertiary care 11. Excisional biopsy remains the most accurate modality of confirmation of the diagnosis, furthered by the use of immunohistochemistry in case of diagnostic doubt.…”
Section: Discussionmentioning
confidence: 99%
“…Excisional biopsy remains the most accurate modality of confirmation of the diagnosis, furthered by the use of immunohistochemistry in case of diagnostic doubt. Sentinel lymph node (SLN) biopsy should be additionally offered with IB–IIC and a Breslow thickness of >1 mm 1112.…”
Section: Discussionmentioning
confidence: 99%
“…The clinical management information detailed earlier is reflected in most melanoma guidelines from around the world, but some contain recommendations that do not appear to be evidence‐based. Eleven guidelines provide specific advice for the management of DM and DNM, 39,41–50 seven simply suggest reporting the subtype in the pathology report, 51–57 and 11 do not address the management of DM as a separate entity 41,58–67 . The guidelines that do provide advice base their recommendations on low‐level evidence (case series) or low‐level evidence in combination with expert consensus.…”
Section: Current National and International Treatment Guidelines For Desmoplastic And Desmoplastic Neurotropic Melanomasmentioning
confidence: 99%
“…Nine guidelines recommend that if a melanoma is of the desmoplastic subtype, this should be noted in the pathology report 39,42,48,50,52–54,56,68 . Two guidelines state that it is important for the reporting pathologist to distinguish between pure and mixed DM 39,52 . Seven guidelines advise that the presence of neurotropism should be reported 42,48,51,53–55,57 …”
Section: Current National and International Treatment Guidelines For Desmoplastic And Desmoplastic Neurotropic Melanomasmentioning
confidence: 99%